COMPANIES COVERED
Abbott LaboratoriesDownload FREE Report Sample
Download Free sampleInflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most common inflammatory bowel diseases are ulcerative colitis and Crohns disease.
Inflammatory Bowel Disease Drugs Market contains market size and forecasts of Inflammatory Bowel Disease Drugs in global, including the following market information:
Global Inflammatory Bowel Disease Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Inflammatory Bowel Disease Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Inflammatory Bowel Disease Drugs companies in 2021 (%)
The global Inflammatory Bowel Disease Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Amino-salicylates Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Inflammatory Bowel Disease Drugs include Abbott Laboratories, Biocon Ltd, Roche, Johnson and Johnson, Mylan Pharmaceuticals, Novartis AG, Pfizer, Quest Medical and Sanofi and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Inflammatory Bowel Disease Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inflammatory Bowel Disease Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Inflammatory Bowel Disease Drugs Market Segment Percentages, by Type, 2021 (%)
Amino-salicylates
Antibiotics
Corticosteroids
Immunomodulators
Biologics
Others
Global Inflammatory Bowel Disease Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Inflammatory Bowel Disease Drugs Market Segment Percentages, by Application, 2021 (%)
Ulcerative Colitis
Crohns Disease
Indeterminate Colitis
Others
Global Inflammatory Bowel Disease Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Inflammatory Bowel Disease Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inflammatory Bowel Disease Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Inflammatory Bowel Disease Drugs revenues share in global market, 2021 (%)
Key companies Inflammatory Bowel Disease Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Inflammatory Bowel Disease Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Biocon Ltd
Roche
Johnson and Johnson
Mylan Pharmaceuticals
Novartis AG
Pfizer
Quest Medical
Sanofi
Takeda Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy